Anvisa informs that, in 2025, the inclusion of data in the SNGPC will be mandatory. Pharmacy professionals have until December 31 to test the tool and clarify doubts

Pharmaceutical Assistance Coordination evaluates proposals in a public session. The announcement of the winning company is expected in 2023, subject to appeals and disqualifications.

Dib was one of the main figures behind the regulation of medicinal cannabis use in Brazil and tomorrow he will clarify doubts about the current Anvisa legislation and discuss the agency's perspectives for the coming years regarding the plant

On the anniversary of the National Health Surveillance Agency (Anvisa), learn about the evolution of the medicinal use of cannabis over the 23 years since the agency was created

The business sector sees great potential for business from the permission to cultivate and process cannabis for industrial purposes, creating a completely new industry with various players.

Decision from the 2nd Federal Court of Guarulhos determines that authorities do not seize oil, cannabis flowers, and vaporizer used in medical treatment by Argentine patient.

Increased demand and bottleneck at the National Narcotics Fund of Colombia cause delays of up to 60 days in certificate issuance and halve exports to Brazil

Check out the confirmed names: Beatriz Marti Emygdio, Filipe Campos, Tarso Araujo, and João Paulo Silvério Perfeito will be among the specialists participating in the event in São Paulo

Deadline set by STJ puts pressure on ministries and Anvisa to conclude pending stages of the action plan

Even with evident clinical improvement, treatment with vaporized cannabis flowers is still limited by legal and bureaucratic barriers

A research by the Federal University of Latin American Integration (UNILA), conducted in partnership with the Santa Cannabis association, will grace the pages of the renowned scientific journal Frontiers in Pharmacology

Explore the scientific foundations and clinical practices that support the use of cannabis in dental treatment

In another column for Sechat, The Green Hub's Head of Business Marcelo De Vita Grecco evaluates the current regulatory scenario of cannabis in Brazil and suggests the possibility of a plan B, at a time when the focus is on the resumption of the legislative process.

The intention of the state foundation, maintained by the Federal Government, stands out due to the fact that, currently, the cultivation of the Cannabis sativa plant is prohibited by Brazilian legislation

Without defined rules, veterinarians face legal uncertainty and animals still have limited access to medicinal cannabis treatment

Unrestricted prohibitions on Cannabis products currently in force are not in line with Anvisa's regulatory microsystem.

Hemp is making its way into makeup with promises of natural beauty, but still faces challenges in regulation and skin science

Change may authorize cultivation by companies under strict control, with a limit of 0.3% THC; measure complies with a decision from the Superior Court of Justice (STJ) related to cultivation regulation.

Court authorization paves the way for personalized and more accessible products for the population

Ongoing research seeks to find solutions to the problems of large-scale cannabis plantations